Buy or sell 4D Molecular Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

View More Companies

4D Molecular Therapeutics Stock

4D Molecular Therapeutics’ mission is to design and develop transformative gene therapy products using our proprietary.

Founded

2013

Headquarters

Emeryville CA, US

Total Funding

$10.0M

About 4D Molecular Therapeutics Stock

4D Molecular Therapeutics, we are unlocking the full potential of the gene therapy field. Our customized AAV vectors can deliver genes to any cell in the body to eradicate disease.

Funding History

August 2015$7.0M
September 2017$3.0M

Management

Co-Founder

David Schaffer

COO

Anthony Davies

Co-Founder, President & CEO

David Kirn

Press

Other Companies

Deep Genomics Logo
Learn More
Learn More
Deep Genomics
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.
$16.7MTotal Funding
IGM Biosciences Logo
Learn More
Learn More
IGM Biosciences
Develops antibodies for treatment of cancer
$102MTotal Funding
Nabi Biopharmaceuticals Logo
Learn More
Learn More
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals develops preventive measures and treatments for diseases.
$10.0MTotal Funding
Seven Bridges Logo
Learn More
Learn More
Seven Bridges
Seven Bridges is the leading biomedical data science company.
$98.0MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from 4D Molecular Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo